Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical Study

BACKGROUND: In addition to demonstrated public health benefits on reducing transmission, it remains unclear how early antiretroviral therapy (ART) must be started after acquisition of human immunodeficiency virus (HIV) to maximize individual benefits. METHODS: We conducted an open-label randomized c...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Javier R. Lama, Rachel Bender Ignacio, Ricardo Alfaro, Jessica Ríos, Jorge A. Gallardo-Cartagena, Rogelio Valdez, Carolyn Bain, Karin Sosa Barbarán, Manuel Villarán, Christopher D. Pilcher, Pedro Gonzáles, Jorge Sánchez, Ann Duerr
Formato:	Artículo
Lenguaje:	inglés
Publicado:	2020
Materias:	Medicine Human immunodeficiency virus (HIV) Antiretroviral therapy Sida Randomized controlled trial Immunology Clinical trial Virology Intensive care medicine Viral disease Viral load Internal medicine Sexual and Gender Minorities Adult Female Humans Male Peru epidemiology HIV Infections drug therapy Homosexuality, Male CD4 Lymphocyte Count Anti-HIV Agents therapeutic use Health Sciences Medicine Infectious Diseases HIV/AIDS Research and Interventions Life Sciences Immunology and Microbiology Virology HIV Research and Treatment Life Sciences Biochemistry, Genetics and Molecular Biology Molecular Biology Biological Research and Disease Studies
Acceso en línea:	Ver en el sistema de origen Ver en el sistema de origen Enlace permanente (DOI o Handle)
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares: Clinical and Immunologic Outcomes After Immediate or Deferred Antiretroviral Therapy Initiation During Primary Human Immunodeficiency Virus Infection: The Sabes Randomized Clinical Study